Carisma Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CARM and buy or sell other stocks, ETFs, and their options commission-free!About CARM
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors.
CEOCraig R. Jalbert
CEOCraig R. Jalbert
Employees46
Employees46
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2016
Founded2016
Employees46
Employees46
CARM Key Statistics
Market cap20.92K
Market cap20.92K
Price-Earnings ratio0.00
Price-Earnings ratio0.00
Dividend yield—
Dividend yield—
Average volume2.64K
Average volume2.64K
High today$0.0005
High today$0.0005
Low today$0.0005
Low today$0.0005
Open price$0.0005
Open price$0.0005
Volume1.42K
Volume1.42K
52 Week high$0.29
52 Week high$0.29
52 Week low$0.0001
52 Week low$0.0001
Stock Snapshot
Carisma Therapeutics(CARM) stock is priced at $0.00, giving the company a market capitalization of 20.92K. It carries a P/E multiple of 0.00.
As of 2026-10-03, Carisma Therapeutics(CARM) stock has fluctuated between $0.00 and $0.00. The current price stands at $0.00, placing the stock 0.0% above today's low and 0.0% off the high.
The Carisma Therapeutics(CARM)'s current trading volume is 1.42K, compared to an average daily volume of 2.64K.
In the last year, Carisma Therapeutics(CARM) shares hit a 52-week high of $0.29 and a 52-week low of $0.00.
In the last year, Carisma Therapeutics(CARM) shares hit a 52-week high of $0.29 and a 52-week low of $0.00.
People also own
Based on the portfolios of people who own CARM. This list is generated using Robinhood data, and it’s not a recommendation.